Engineered for global brand owners, healthcare practitioners, and Amazon power sellers. Delivering high-potency rTG, ethyl ester, targeted-release enteric, and plant-based algal Omega-3 softgels under strict cGMP and GOED quality standards.
Nitrogen-purged zero-oxygen encapsulation suites
Full GC-MS and ICP-MS testing on every batch
FDA-registered Springville, Utah facility
Global sourcing managers and brand owners face three persistent bottlenecks when contracting Omega-3 softgel production: sensory degradation caused by thermal oxidation (high TOTOX), batch-to-batch fill variance in high-concentration oils, and consumer complaints regarding reflux ("fishy burps"). As a premier CDMO, PAG Pharmatech re-engineers softgel encapsulation through scientific rigor and specialized equipment design.
Omega-3 polyunsaturated fatty acids (PUFAs) contain sensitive double bonds vulnerable to atmospheric oxygen, light, and heat. Secondary oxidation creates volatile aldehydes responsible for rancidity. PAG prevents oxidation through continuous inert nitrogen purging during oil holding, gelatin ribbon preparation, and rotary die filling.
Ethyl Ester (EE) formulations are economical but suffer from reduced pancreatic lipase hydrolysis efficiency in the human digestive tract. Re-esterified Triglyceride (rTG) forms match natural lipid structures, accelerating intestinal absorption by up to 70%. PAG provides both, fully optimized for mass-market or clinical-grade lines.
Standard gelatin softgels dissolve rapidly in stomach acid (pH 1.2–2.0), releasing light lipid layers that float on gastric fluids and cause belching. PAG’s enteric coating matrix resists gastric breakdown, delaying rupture until the softgel encounters the neutral pH (6.8) of the duodenum, completely eliminating fishy aftertaste.
PAG Pharmatech provides custom and turnkey contract manufacturing across five primary Omega-3 product categories, engineered for maximum compliance, stability, and consumer adherence.
Re-esterified Triglyceride concentrates offering up to 90% total Omega-3 content (e.g., 500mg EPA / 250mg DHA per 1000mg fill). Delivers maximum therapeutic dose per capsule with minimal pill volume.
Inquire Now
Gastric acid-resistant softgels manufactured using specialized pectin-gelatin polymer shells or post-encapsulation aqueous coating. Guarantees zero gastric reflux and enhanced intestinal bio-accessibility.
Inquire Now
100% plant-based Omega-3 derived from fermentative Schizochytrium algae. Encapsulated in non-GMO tapioca starch or carrageenan softgel shells to satisfy vegan and eco-conscious market segments.
Inquire Now
Multi-active oil blends combining high-purity Omega-3 with natural Astaxanthin, CoQ10 (Ubiquinol), Vitamin D3 + K2 (MK-7), or Phospholipids for premium cardiovascular, joint, and cognitive positioning.
Inquire Now
Soft chewable gel capsules formulated with natural fruit flavors (orange, lemon-lime) and stevia/xylitol sweetener matrices. Designed to burst smoothly in the mouth without residual fishiness.
Inquire Now
Cost-optimized, high-volume standard 180mg EPA / 120mg DHA baseline softgels. Ideal for mass-market retail channels, club store multi-packs, and value-focused private label catalog expansion.
Inquire NowUnderstanding the lipid chemistry behind Omega-3 softgels is essential for product formulation engineers and brand managers aiming to substantiate premium marketing claims.
| Lipid Molecular Form | Chemical Structure Details | Relative Bioavailability | Enzymatic Cleavage Speed | Manufacturing Complexity |
|---|---|---|---|---|
| Re-esterified Triglyceride (rTG) | 3 fatty acids esterified back to a glycerol backbone post-distillation | 124% – 170% (Highest) | Immediate by Pancreatic Lipase | High (Requires specialized nitrogen drying) |
| Ethyl Ester (EE) | 1 fatty acid attached to an ethanol molecule via molecular transesterification | 100% (Baseline Reference) | Slower (Requires bile salt emulsification first) | Standard Commercial Processing |
| Natural Triglyceride (TG) | Unconcentrated crude fish oil structure (typically 18/12 concentration) | 100% – 120% | Fast hydrolysis | Low / High Fill Volume per Dose |
| Algal DHA/EPA (Vegan TG) | Microalgae fermentation-derived natural triglyceride matrix | 130% – 150% | Immediate hydrolysis | Specialized Plant-Gel Shell Compatibility |
Our Springville, Utah manufacturing facility operates strictly under US FDA 21 CFR Part 111 (Dietary Supplement cGMP) and 21 CFR Part 117 (Preventive Controls for Human Food), audited independently by SGS for SQF Edition 9 compliance.
Measures primary oxidation. Every raw marine and algal oil shipment undergoes cold-chain receipt verification and automated titrimetric peroxide analysis before release into production.
Measures secondary oxidation (2-alkenals and 2,4-dienals). Spectrophotometric testing confirms thermal stability during processing, guaranteeing clean sensory profile and zero fishy odor.
Calculated as [2 x PV + AV]. PAG’s target TOTOX levels during encapsulation sit between 6 and 12, far surpassing the GOED monograph maximum standard of 26.
Inductively Coupled Plasma Mass Spectrometry verifies non-detectable levels for Lead (<0.01 ppm), Mercury (<0.005 ppm), Cadmium (<0.01 ppm), Arsenic, and Dioxins/PCBs.
As consumer awareness matures, buyer requirements are shifting rapidly from low-cost commoditized fish oils toward high-concentration, sustainably sourced, and micro-encapsulated lipid delivery systems.
Driven by ocean sustainability concerns, overfishing regulations, and expanding vegan demographics, microalgae-derived Omega-3 demand is growing at 14.2% CAGR. PAG’s non-animal starch softgel lines allow brands to lead this premium sector.
Consumers reject taking 3 to 4 large softgels daily. High-concentration oils (>80% active payload) enable concentrated 1-softgel daily dosing regimens (e.g., 1000mg softgel delivering 800mg total EPA+DHA).
Global retailers now demand full chain-of-custody documentation, including MSC (Marine Stewardship Council) and Friend of the Sea certification, ensuring oil is sourced from unpolluted, sustainable fisheries.
Combining Omega-3 with fat-soluble phytonutrients (Curcumin, Lutein, CoQ10) in self-emulsifying drug delivery systems (SEDDS) to maximize cellular absorption without increasing softgel shell size.
We are a fully integrated Contract Development and Manufacturing Organization (CDMO). We operate our own automated continuous encapsulation lines and analytical laboratories inside our Springville, Utah facility.
Automated Rotary Die Encapsulation On-Site Analytical QC Lab Climate-Controlled Tumble Drying From initial oil specification to finished product release, our structured CDMO workflow guarantees batch shipment within 8 to 12 weeks, accelerating your market entry.
Accessible batch sizes starting at 5,000 bottles (or 300,000 bulk softgels), allowing growing brands to introduce premium rTG or Algal SKUs with managed inventory exposure.
Utah plant for US domestic production, Netherlands EU-GMP site for European compliance, and Shenzhen hub for high-volume raw material procurement leverage.
Full batch documentation including Certificate of Analysis (CoA), Master Batch Records (MBR), Allergen Statements, and Stability Data structured for Amazon and retail audits.
Technical solutions and regulatory insights for procurement officers, quality assurance leads, and brand founders.
Preventing lipid oxidation requires precise control over thermal and atmospheric variables throughout the manufacturing process. PAG Pharmatech employs closed-loop, stainless steel reaction vessels flushed continuously with high-purity inert nitrogen gas. From raw oil receiving and holding to gelatin ribbon formation and rotary die filling, oxygen exposure is eliminated. Our tumble dryers and static drying rooms maintain strict relative humidity (20%–22%) and temperature controls (20°C–22°C), preventing thermal oxidation. Every production run undergoes immediate Peroxide Value (PV) and Anisidine Value (AV) titrations, ensuring a final TOTOX level well below the GOED industry threshold of 26.
Bovine or porcine gelatin shells melt at approximately 35°C–40°C and set rapidly on cooling drums, allowing high-speed encapsulation. In contrast, plant-based vegan softgels—utilizing modified tapioca starch, carrageenan, or pectin—require higher sealing temperatures (60°C–70°C) and specialized die roll geometry. Plant gels possess different elasticity and moisture retention properties, requiring extended tumble drying cycles and precise humidity management to prevent shell leached seals or micro-leakage. PAG Pharmatech operates dedicated plant-gel encapsulation machinery engineered specifically for high-volume vegan algal Omega-3 production.
Yes. Traditional enteric coating involved dipping softgels in organic solvent solutions, which often caused gelatin cross-linking and shell brittleness over time. PAG Pharmatech offers two advanced acid-resistant options: 1) Aqueous-based enteric film coating applied via perforated pan coaters using pharmaceutical-grade methacrylic acid copolymers or sodium alginate; 2) In-gel enteric matrix encapsulation, where enteric polymers are blended directly into the gel mass prior to encapsulation. Both methods pass USP <2040> Disintegration testing: resisting simulated gastric fluid (pH 1.2) for 60 minutes, followed by rapid breakdown in intestinal fluid (pH 6.8) within 15 to 30 minutes, preventing gastric reflux completely.
Our standard minimum order quantity (MOQ) for custom Omega-3 softgel manufacturing is 300,000 bulk softgels (approximately 5,000 bottles packed in 60-count configurations). For private label formulations utilizing our pre-validated high-concentration rTG or EE stock oils, lead times range from 8 to 10 weeks. Fully custom formulations involving specialty active combinations (e.g., Omega-3 + Astaxanthin + Vitamin K2) or novel shell colors/molds typically require 10 to 12 weeks, inclusive of pilot scale-up, analytical method validation, and finished product packaging.
Quality assurance is embedded in our manufacturing workflow. Raw oils undergo incoming testing via Gas Chromatography-Mass Spectrometry (GC-MS) to quantify exact EPA/DHA fatty acid profiles and verify the absence of environmental contaminants. Heavy metals (Lead, Cadmium, Mercury, Arsenic) are screened using Inductively Coupled Plasma Mass Spectrometry (ICP-MS) with detection limits down to parts-per-billion (ppb). We also test for polychlorinated biphenyls (PCBs), dioxins, and furans. Every commercial batch is issued a comprehensive Certificate of Analysis (CoA) matching or exceeding IFOS (International Fish Oil Standards) 5-Star specifications and GOED monograph compliance.
Each production lot includes a complete compliance package designed to satisfy Amazon seller verification, FDA inspectors, and retail merchant audits. This includes: 1) Finished Product Certificate of Analysis (CoA) detailing potency, microbiological purity, and oxidation parameters; 2) Executed Master Batch Record (MBR) detailing weighing, encapsulation, drying, and inspection logs; 3) Heavy Metal & Contaminant Analytical Reports; 4) Statement of Origin and Non-GMO Declaration; 5) Certificate of Free Sale and cGMP Compliance Certificate. Copies of our Utah FDA registration and SQF Edition 9 certification are provided under NDA during vendor qualification.
Yes. PAG operates a Global Integrated System linking our main production facility in Springville, Utah with our EU-GMP facility in the Netherlands and our Asian sourcing hub in Shenzhen. By utilizing identical Master Manufacturing Formulas (MMF), standardized raw material specifications, and synchronized quality management systems, your brand can scale regional manufacturing across North America, Europe, and Asia without repeating initial formulation development or re-qualifying separate contract manufacturers.
Consult with our Utah-based softgel R&D scientists and commercial procurement team. Receive a fully costed manufacturing proposal, master specification review, and sample kit within 24 to 48 hours.
FDA registration does not constitute FDA approval or endorsement of any finished dietary supplement product. All manufacturing operations are conducted in accordance with 21 CFR Part 111 and Part 117 cGMP regulations. Certificates of Analysis and audit documentation are available under NDA during formal supplier qualification.
